Hypertension Clinical Trial
To determine ways in which behavioral factors influenced the diagnosis and development of hypertension in adult working populations.
BACKGROUND:
The causes of essential hypertension remain unknown, but it is generally agreed that both
genetic and environmental factors are important. Of the latter, the two leading contenders
are nutrition including sodium intake and weight gain, and psychosocial stress. It is
probable that no single factor is responsible, and that hypertension is most likely to
develop when a number of factors act in unison, so that different mechanisms operate in
different individuals. It also seems probable that there may be two different components to
the development of hypertension, with differing time courses. First, there are a number of
mechanisms which produce rapid changes of blood pressure, which are not necessarily
sustained for very long. Prime among these are the sympathetic nervous system and the
renin-angiotensin system. Although derangements of both have been described in patients with
essential hypertension, neither can on its own explain the overall mechanism. Secondly,
there is also a slowly occurring hypertrophy of the arterial wall, which occurs partly in
response to the transient increases of pressure, but also acts as a positive feedback loop,
serving to amplify them. It seems probable that a number of different mechanisms may be
involved in the first process, possibly including the effects of psychosocial stress and
nutrition, but that the slow mechanism may be the final common path which maintains and
amplifies the development of hypertension independently of the initiating causes. While the
relevance of behavioral factors, or stress in hypertension is commonly accepted by the lay
public, it has found much less acceptance among their physicians. This is perhaps not
surprising, because stress is so hard to quantify on a scientific basis, particularly when
it is borne in mind that there is still no agreement about the role of sodium intake, which
is comparatively easy to quantify, in the development of hypertension. The treatment of
patients with mild hypertension is a major public health issue. There are two possible
strategies to counter the costs and side effects of universal pharmacological treatment,
namely, defining high risk patients and finding safer methods of treatment. Patients with
white coat hypertension show elevations of blood pressure only in the clinic situation. If
it can be demonstrated that individuals with white coat hypertension are not at increased
risk and do not exhibit the physiological and biochemical characteristics normally
associated with early hypertension, such individuals will not necessarily require drug
treatment but may be treated by desensitization. Also, the studies on job strain may enable
identification of some environmental risk factors which may have an adverse effect on
certain individuals' blood pressure. If job strain does influence blood pressure, it
presents the possibility of an entirely new non-pharmacological method of preventing or
treating hypertension, through manipulation of the work environment.
DESIGN NARRATIVE:
When the study was initiated in 1984, five interdisciplinary studies were conducted. Study 1
followed 1,500 hypertensive patients who had ambulatory blood pressures recorded over the
last ten years, to determine whether ambulatory blood pressure improved the prediction of
morbid events relative to clinic blood pressures. Study 2 evaluated factors contributing to
white coat hypertension, and whether it could be treated behaviorally. Study 3 compared the
reactivity to beta-adrenergic stimulation and to behavioral tasks in normals and patients
with hypertension or depression. Study 4 tested the Job Strain Model in the laboratory by
investigating the interactive effects on blood pressure of varying levels of workload or
task difficulty and decision latitude or degree of personal control during a challenging
behavioral task. Generalization of this measure of reactivity was assessed by comparison
with ambulatory blood pressure recordings. Study 5, in a cohort study of 400 subjects,
determined whether individuals in high-strain jobs showed greater elevations of blood
pressure over five years than those in low-strain jobs.
The study was renewed for one year in 1993 as a continuation and extension of the study of
the association between occupational stress ('job strain', evaluated by the Karasek Job
Content Survey) and hypertensive cardiovascular disease, evaluated principally by ambulatory
blood pressure (ABP) and left ventricular mass index (LVMI). It was originally a case
control study in which cases (hypertensive subjects) were found to be more likely to be
exposed to job strain than normotensive controls, with an odds ratio of 2.75, and to have a
greater LVMI. This effect was independent of other known risk factors for hypertension. It
was extended as a prospective study of 314 men and women studied at 9 worksites during Waves
of observation over five years. Preliminary results from Waves 1 and 2 showed a longitudinal
association between persistent job strain and progressive elevation of ABP.
In the renewal, the investigators increased the sample size by 100 subjects and added a 4th
Wave of observation. In Wave 3, they added a new outcome measure-ultrasound examination of
the carotid artery, which detected early structural changes and atherosclerosis. They also
monitored physical activity continuously during ABP monitoring using an Actigraph monitor. A
new focus wass on social support, which had been shown to relate to cardiovascular
morbidity, possibly via an interaction effect with job strain. The investigators evaluated
how its availability and perceived satisfaction interacted with job strain and their outcome
measures. The effects of job strain on urinary catecholamines and cortisol were also
examined in 210 subjects, to test the hypothesis that job strain was associated with an
overactivity of both the sympathetic nervous system and adrenocortical system, by analogy
with Frankenhaueser's Effort-Distress model. In Wave 4 they also performed reactivity
testing, in order to examine correlations between reactivity, atherosclerosis, and other
cardiovascular variables. The research helped to determine whether sequential linkages
existed between major psychosocial factors (job strain and lack of social support),
mechanisms mediating cardiovascular damage (elevated ABP and sympathoadrenal activation),
and resultant preclinical cardiovascular disease (left ventricular hypertrophy and carotid
atherosclerosis).
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |